Versartis Trial in Children to Assess Long-Acting Growth Hormone

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Pediatric Growth Hormone Deficiency

Interventions

DRUG

Experimental: VRS-317

Active treatment arm

Trial Locations (23)

Clovis

Los Angeles

San Diego

San Francisco

Greenwood Village

Orlando

Tallahassee

Tampa

Atlanta

Indianapolis

Baltimore

Springfield

Minneapolis

Kansas City

Livingston

Morristown

Buffalo

Mineola

Sleepy Hollow

Cleveland

Columbus

San Antonio

Seattle

All Listed Sponsors

lead

Versartis Inc.

INDUSTRY

NCT01718041 - Versartis Trial in Children to Assess Long-Acting Growth Hormone | Biotech Hunter | Biotech Hunter